April 20, 2020Catheterization and Cardiovascular Interventions
Management of acute myocardial infarction during the COVID ‐19 pandemic
Why the study?
Cardiovascular manifestations of COVID-19 are complex and disease prevalence is uncertain, creating challenges that require recommendations for a systematic approach to acute myocardial infarction care.
Population
Patients with acute myocardial infarction during the COVID-19 pandemic
Design
Recommendation document
Authors
Discussion
Loading...
Member takes
Implication
Offers interim recommendations for ischemic heart disease care during COVID-19; leaves open validation of safety and outcomes in prospective studies.
Structured PICO
P
Population
Patients presenting with acute myocardial infarction (AMI) during the COVID-19 pandemic
I
Intervention
Systematic approach for AMI care including primary percutaneous coronary intervention (PCI) with appropriate personal protective equipment (PPE) at PCI-capable hospitals, or fibrinolysis at non-PCI-capable hospitals
This document provides recommendations for managing AMI during the COVID-19 pandemic, reaffirming primary PCI as the standard of care for STEMI when feasible with appropriate PPE.
Cite This Study
Mahmud et al. (2020) conducted a review in Acute myocardial infarction during COVID-19. Management of acute myocardial infarction (primary PCI or fibrinolysis) was evaluated. Primary percutaneous coronary intervention remains the standard of care for STEMI patients during the COVID-19 pandemic when provided timely with appropriate personal protective equipment.